NeuroOne Medical Technologies (NMTC) said late Thursday it began a proposed underwritten registered public offering of its shares.
The company will sell all the shares of common stock in the offering.
In addition, the company intends to grant the underwriter a 45-day option to purchase up to an additional 15% of the shares sold in the offering.
Shares NeuroOne Medical were down over 36% in after-hours activity.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.